Pay in 4 interest-free payments of $5.81 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase [PMID: 26308058] Laboratory literature summary: Mitochondrial Impairment May Increase Cellular NAD(P)H: Resazurin Oxidoreductase Activity, Perturbing the NAD(P)H-Based Viability Assays
Injection Site: Common injection sites include the abdomen or thigh
Movement does not need to be punishing to count
Many peptides are supplied as lyophilized (freezedried) powder, which is generally more stable than peptides stored in solution
Table 4 provides details on the risk of bias assessment for each study
US$ 23.87
US$ 29.39
US$ 20.70
US$ 20.56
US$ 28.65
US$ 25.60
US$ 25.89
